SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-008718
Filing Date
2023-03-23
Accepted
2023-03-23 17:06:05
Documents
110
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2243761
2 ex4-1.htm EX-4.1 180896
3 ex21-1.htm EX-21.1 10286
4 ex23-1.htm EX-23.1 4358
5 ex31-1.htm EX-31.1 17402
6 ex31-2.htm EX-31.2 15039
7 ex32-1.htm EX-32.1 7500
8 ex32-2.htm EX-32.2 7318
  Complete submission text file 0001493152-23-008718.txt   11217675

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE hrow-20221231.xsd EX-101.SCH 87357
10 XBRL CALCULATION FILE hrow-20221231_cal.xml EX-101.CAL 108365
11 XBRL DEFINITION FILE hrow-20221231_def.xml EX-101.DEF 419859
12 XBRL LABEL FILE hrow-20221231_lab.xml EX-101.LAB 688205
13 XBRL PRESENTATION FILE hrow-20221231_pre.xml EX-101.PRE 554466
104 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1708081
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 23756999
SIC: 2834 Pharmaceutical Preparations